Psychedelics are a hot topic, and a drug called ibogaine is receiving attention after a recent shoutout from U.S. President Donald Trump. University of Calgary psychedelics researcher Leah Mayo explains what ibogaine is, and why limited high-quality research has her hesitant to recommend it.For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Dose
Why do I need to know about Legionnaires' disease?
What do I need to know about hantavirus?
What can erectile dysfunction say about men’s health?
What can a full-body MRI actually tell me about my health?
Get summaries like this every morning.
Free AI-powered recaps of The Dose and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.